BlackRock Capital Allocation Term Trust (NYSE:BCAT) Sees Unusually-High Trading Volume

Posted by Anthony Bellafiore on Jul 5th, 2024

BlackRock Capital Allocation Term Trust (NYSE:BCAT – Get Free Report) saw strong trading volume on Friday . 244,753 shares were traded during trading, a decline of 27% from the previous session’s volume of 333,555 shares.The stock last traded at $16.66 and had previously closed at $16.60.

BlackRock Capital Allocation Term Trust Stock Performance

The firm has a 50 day moving average price of $16.25 and a 200 day moving average price of $15.76.

BlackRock Capital Allocation Term Trust Increases Dividend

The company also recently declared a monthly dividend, which will be paid on Wednesday, July 31st. Stockholders of record on Monday, July 15th will be paid a dividend of $0.2865 per share. The ex-dividend date of this dividend is Monday, July 15th. This represents a $3.44 annualized dividend and a dividend yield of 20.42%. This is a positive change from BlackRock Capital Allocation Term Trust’s previous monthly dividend of $0.10.

Hedge Funds Weigh In On BlackRock Capital Allocation Term Trust

Institutional investors have recently made changes to their positions in the company. Sugarloaf Wealth Management LLC purchased a new position in BlackRock Capital Allocation Term Trust in the fourth quarter valued at about $25,000. Bfsg LLC purchased a new position in BlackRock Capital Allocation Term Trust in the fourth quarter valued at about $41,000. CWM LLC purchased a new position in BlackRock Capital Allocation Term Trust in the fourth quarter valued at about $62,000. Private Advisor Group LLC purchased a new position in BlackRock Capital Allocation Term Trust in the fourth quarter valued at about $177,000. Finally, Claro Advisors LLC grew its stake in BlackRock Capital Allocation Term Trust by 9.9% in the fourth quarter. Claro Advisors LLC now owns 17,736 shares of the company’s stock valued at $265,000 after purchasing an additional 1,603 shares during the last quarter. Hedge funds and other institutional investors own 36.12% of the company’s stock.